Neurology Today Discussing CHeBA Research

CHeBA News: Neurology Today Discussing CHeBA Research
CHeBA News: Neurology Today Discussing CHeBA Research

This article covers some of CHeBA's latest research.

Experts discuss the clinical importance of three new papers that support the theory that early white matter injury may be a preclinical marker for age-related cognitive decline and for Alzheimer's disease.

Read the article: White Matter Injury Found to Be Preclinical Marker for Age-related Cognitive Decline, Neurology Today (528kb, PDF)

Communications Contact

Communications contact: Heidi Douglass, Communications and Projects OffierHeidi Douglass
Communications & Projects Officer
T 0435 579 202
E h.douglass@unsw.edu.au